Formulations of abaloparatide, transdermal patches thereof, and uses thereof

FORMULATIONS OF ABALOPARATIDE, TRANSDERMAL PATCHES THEREOF, AND USES THEREOF Disclosed are abaloparatide formulations for transdermal delivery of a therapeutically effective amount of abaloparatide, as well as transdermal patches prepared using these formulations, methods of preparing the disclosed formulations and patches, and methods of using these formulations and patches to treat osteoporosis, osteopenia, osteoarthritis, and/or bone fracture, improve bone mineral density (BMD), improve trabecular bone score (TBS), and treat, prevent, and/or reduce bone fractures..

Medienart:

Patent

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Europäisches Patentamt - (2023) vom: 13. Juli Zur Gesamtaufnahme - year:2023

Sprache:

Englisch

Beteiligte Personen:

HATTERSLEY GARY [VerfasserIn]
HARRIS ALAN [VerfasserIn]
SAEH JAMAL [VerfasserIn]
HAMED EHAB [VerfasserIn]
BROWN KENNETH [VerfasserIn]
DOHMEIER DANIEL [VerfasserIn]
MOSEMAN JOAN [VerfasserIn]
ZHANG YING [VerfasserIn]
DICK LISA [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61K: Preparations for medical, dental, or toilet purpose (...)
C07K: Peptides (peptides containing β-lactam rings c07d; (...)
che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2023-07-13, Last update posted on www.tib.eu: 2023-11-27, Last updated: 2023-12-01

Patentnummer:

AU2021204233

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA015166937